v3 Template
N

National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)

Biopharmaceutical Manufacturing Newark, Delaware, USA ~420 employees
Founded
--
Employees (Est.)
~420
21 leaders known
Total Funding
$10.5M
Funding Rounds
1
Last Funding
2025-10-23

About National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)

NIIMBL (National Institute for Innovation in Manufacturing Biopharmaceuticals) drives U.S. leadership in biopharmaceutical manufacturing by collaborating on innovative manufacturing platforms and technologies. Their mission is to accelerate the development and manufacture of life-saving medicines, enhance national economic security, support biothreat response, and ensure therapies reach patients quickly through industry solutions and workforce development.

Products & Services

Projects & Programs:Includes initiatives like the Viral Vector Program, Big Data Program, Process Intensification Program, and Preventive Medical Countermeasures Program to advance biopharmaceutical manufacturing technologies.
Industry Solutions:Offers solutions like Biomanufacturing Readiness Levels (BRLs), Buffer Stock Blending System, and NIIMBL Roadmaps to help companies de-risk adoption of new technologies.
Workforce Development:Programs like NIIMBL eXperience, NIIMBL bioLOGIC, and Faculty Fellows to cultivate a skilled biopharmaceutical workforce through training and education.

Specialties

Biopharmaceutical Manufacturing Innovation Viral Vector Technology Big Data in Bioprocessing Process Intensification Vaccine Manufacturing Workforce Training and Education Advanced Process Analytics AI/ML for Bioprocess Optimization

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Grant
T: -
FT: Grant
A: 10500000
MR: -
FA: $10.5 Million
FAN: 10500000
D: 2025-10-23
FD: 2025-10-23
1 investors
Grant Latest
2025-10-23
$10.5M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

J

John Balchunas

Director, Workforce

B

Barry Buckland

Executive Director

R

Ryan G. Chatman

Director, Business Operations

D

Dawn Jory, CRA

Director, Sponsored Programs

K

Kelvin H. Lee

Institute Director

S

Sara Merriman

Director, Member Engagement & Strategy

View 18 more team members with Pro

Unlock Full Team Directory

Recent News

National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Website
niimbl.org
Industries
Biopharmaceutical Manufacturing
Company Size
~420 employees (est.)
Locations
Newark, Delaware, USA

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro